March 1, 2021: Update on COVID-19 Vaccine Distribution

Dear Colleagues,

As you may have heard, over the weekend the FDA authorized the emergency use of the Janssen/Johnson & Johnson’s COVID-19 vaccine for individuals 18 and older. This was followed by the CDC’s Advisory Committee on Immunization Practices’ (ACIP) recommendation and endorsement of this one-dose vaccine.

On Tuesday March 2nd, CDC will hold a conference call for clinicians, “What Clinicians Need to Know About the Janssen COVID-19 Vaccine.” CDC experts will discuss the vaccine’s characteristics and administration, vaccinating special populations, contraindications, and more. Zoom and dial in instructions are here(link is external and opens in a new window).

Vaccinations will continue on March 2nd.

The Armory site is open for scheduled appointments, as well as for CUIMC employees as below.

CUIMC Employees

Patient and Community Vaccinations at the Armory

Frequently Asked Questions (FAQs)

The FAQ documents on the CUIMC COVID Vaccine Information page(link is external and opens in a new window) continue to be updated, so please check the site for the latest versions.

As of today, over 47,000 faculty, staff, and students at NewYork-Presbyterian, Weill Cornell, and Columbia have received their first dose of the vaccine and more than 41,000 have received second doses. This includes over 30,000 first and second doses administered on the CUIMC campus alone.

Below is the Question of the Day:

I am a frontline healthcare worker and would like to get vaccinated. Where do I go? Do I need an appointment?

All first doses are now administered at the Armory location in Washington Heights. There is no scheduling for first doses, and frontline health care workers can walk in without an appointment during regular hours of operation.

Thank you and stay safe!

Magda Sobieszczyk MD, MPH
Chief of Infectious Diseases and Co-Chair of the CUIMC COVID-19 Vaccine Committee

Melissa Stockwell MD, MPH
Chief of the Division of Child and Adolescent Health and Co-Chair of the CUIMC COVID-19 Vaccine Committee